 Uterine sarcomas account for less than 5 of all carcinomas of the uterine corpus. The prognosis of these patients is extremely limited. Recurrence rates of 50-60 are reported even for early-stage disease FIGO III. Median overall survival is below 12 months in patients with advanced or metastatic disease. 